Log in or Sign up for Free to view tailored content for your specialty!
Obesity News
Income, insurance status contributes to rationing prescription drugs due to cost
SAN ANTONIO — Due to structural barriers such as low income and inadequate insurance coverage, Black and Hispanic adults were more likely to ration prescription drugs to save money, researchers reported.
High- vs. moderate-intensity exercise reduces ghrelin levels regardless of sex
Regardless of sex, high- vs. moderate-intensive exercise may better reduce ghrelin levels, but its effect on hunger perceptions may differ between men and women, according to results published in the Journal of the Endocrine Society.
Log in or Sign up for Free to view tailored content for your specialty!
Daily oral semaglutide confers weight loss vs. placebo; similar vs. weekly injectables
SAN ANTONIO — Once-daily oral semaglutide conferred more weight loss vs. placebo plus lifestyle intervention and was similar vs. larger oral GLP-1 receptor agonist doses and weekly injectables for efficacy and safety, a speaker reported.
What specific risk factors do you discuss with patients who are prescribed GLP-1 agonists?
Recent research has suggested that GLP-1 agonists used to treat obesity might be associated with a stroke in the optic nerve, but association is not the same as causation.
Specialists discuss concerns over impact of semaglutide on the eye
A paper recently published in JAMA Ophthalmology by Hathaway and colleagues at Harvard suggested a potential association between prescribed semaglutide and an increased risk for nonarteritic anterior ischemic optic neuropathy.
More research needed on possible ocular side effects of semaglutides
Drugs utilized to treat systemic diseases can do harm to the eye and its neural connections.
Swallowable capsule that expands in stomach shows weight-loss, cardiometabolic benefit
SAN ANTONIO — A swallowable hydrogel capsule that expands in the stomach demonstrated significant weight-loss, cardiovascular, glycemic and quality of life benefits for patients with overweight or obesity, a speaker reported.
VIDEO: ‘We are in a new era of the treatment of obesity,’ but inequity concerns persist
SAN ANTONIO — In this Healio video exclusive from ObesityWeek, Fatima Cody Stanford, MD, MPH, MPA, MBA, MACP, FAAP, FAHA, FTOS, discusses equitable access to obesity care and treatments in the U.S.
GPT-4 responses to anti-obesity medication questions comparable to FDA answers
SAN ANTONIO — When asked common questions regarding anti-obesity medications, GPT-4 responses were easy to interpret, accurate and comparable to responses provided by the FDA, according to findings presented at ObesityWeek.
High phthalate, plasticizer metabolite concentrations tied to metabolic syndrome in young
SAN ANTONIO — Higher concentrations of some phthalate and plasticizer metabolites were associated with higher odds of metabolic syndrome in U.S. adolescents and young adults, according to an analysis presented at ObesityWeek.
-
Headline News
Rise in alcohol use during pandemic endures as 'an alarming public health issue'
November 14, 20242 min read -
Headline News
AI identified patient messages sent by proxies, but also broke confidentiality
November 14, 20242 min read -
Headline News
Diabetes inequities persist worldwide, especially for low-, middle-income countries
November 14, 20243 min read
-
Headline News
Rise in alcohol use during pandemic endures as 'an alarming public health issue'
November 14, 20242 min read -
Headline News
AI identified patient messages sent by proxies, but also broke confidentiality
November 14, 20242 min read -
Headline News
Diabetes inequities persist worldwide, especially for low-, middle-income countries
November 14, 20243 min read